Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AP1B1P1 (AP1B1 Pseudogene 1) is classified as a pseudogene, meaning it is a non-functional copy of the AP1B1 gene. It does not encode a protein product and currently has no attributed biological function, disease association, or known drug interactions. Although it shares sequence similarity to the functional AP1B1 gene—which encodes a subunit of the clathrin-associated adaptor protein 1 complex involved in intracellular vesicle trafficking—AP1B1P1 is not known to be expressed as a functional protein and is not considered a therapeutic target[5][7]. This gene is included in genomic databases for reference and annotation purposes only, and should not be confused with its functional paralog, AP1B1[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AP1B1 Pseudogene 1 (AP1B1P1).